Information Collection Request

Human Drug Compounding Under Sections 503A and 503B of the Federal Food, Drug, and Cosmetic Act

ICR 202210-0910-015 · OMB 0910-0800 · Received in OIRA

Forms and Documents
DocumentTypeStatusAvailability
0800 503A 503B SSA 2022 REV.docx Supporting Statement A Uploaded 2022-10-25 Repair queued
IC Document Collections
IC IDCollectionTypeStatusForm
256583 Outsourcing Facilities: Registration and reporting of drugs under 503B(b) Other-Statutory Authority New
241793 503A; Disclosure Other-Memorandum of Understanding Unchanged
241792 503A; Recordkeeping Other-Memorandum of Understanding Unchanged
241791 503A; Reporting Other-Memorandum of Understanding Unchanged
217572 503B Recordkeeping; AERs Other-Guidance Unchanged
217571 503B Reporting: AERs Other-Guidance Unchanged
ICR Details
StatusReceived in OIRA
Agency/SubagencyHHS/FDA
OMB Control No0910-0800
Type of Information CollectionRevision of a currently approved collection
Previous ICR Reference No202005-0910-004
Agency Tracking NoCDER
Date Submitted to OIRA1969-12-31
Requested Expiration Date1969-12-31